Having trouble finding an allergy medicine that works well for you? If so, I have some good news. A brand new nasal steroid spray has just been rolled out in the United States this month (April 2012) and is available by physician prescription.
Teva Pharmaceutical Industries Ltd. announced at the end of March that the U.S. Food and Drug Administration (FDA for short) had approved their application to introduce a medication called QNASL Nasal Aerosol into the U.S. for the treatment of both seasonal and year-round allergic rhinitis, which is a fancy name for nasal allergies.
QNASL is the first of its kind, a "dry" nasal corticosteroid that may provide more comfort and convenience than the water-based (aqueous) sprays currently available. Many patients don't like the liquid dripping down the back of their throat after using a standard nasal spray. QNASL won't cause that post-nasal dripping.
As an HFA inhaler (like asthma inhalers), it is also environmentally-friendly. Plus, it has a built-in dose counter, which can help you know when to refill before you run dry.
This new allergy medicine is designed for
adults and adolescents 12 years of age and older.
Nasal steroids are now considered first-line treatment choices for nasal allergies, but prior to QNASL coming onto the market, all other nasal steroids were only available in the aqueous-based formulas. Some people worry that steroids won't be safe to take, but the truth is, the kind of steroid used in nasal sprays or asthma inhalers are quite safe, which is why they are recommended even for children.
As with any medication, there are certain safety precautions to be aware of and there is always some risk of side effects, though in this case, it is fairly low. Your best bet is to learn more about QNASL and then to talk it over with your doctor about whether it might be a viable treatment choice for your nasal allergy symptoms.
And you may also want to review my article on Choosing the Right Allergy Medicine for You.